15th Annual Highlights of ASCO
This program is designed for physicians, PAs, nurse practitioners, registered nurses, medical staff and pharmacists in Wisconsin and neighboring states wanting to learn about the latest updates in cancer treatment. The conference is designed to review the current clinical updates from the American Society of Clinical Oncology (ASCO) annual meeting. The conference will educate regarding practice-changing findings presented at ASCO 2022.
This conference is being held virtually.
Target Audience
This course is intended for physicians, PAs, nurse practitioners, registered nurses, medical staff and pharmacists in Wisconsin and neighboring states wanting to learn about the latest updates in cancer treatment.
Learning Objectives
At the end of this session, learners should be able to:
- Review highlights of the advances in clinical and translational research presented at the 2022 ASCO® annual meeting
- Identify emerging trends and strategies designed to improve the quality of symptom management and survivorship care
- Evaluate tools and resources in specific areas of cancer management that can be used to achieve effective cancer care delivery and improve the patient experience
7:30am: Exhibits Open
8:30am: Program Overview Michael P. Mullane, MD
8:45am: Genitourinary Cancer Update Toni Choueiri, MD
9:15am: Lung Cancer Update Lawrence H. Einhorn, MD
9:45am: Breast Cancer Update Kari Wisinski, MD
10:15am: Break / Exhibits
10:30am: GI Malignancy Update Edward James, MD
11:00am: Precision Medicine Update Nataliya Uboha, MD, PhD
11:30am: Lymphoma Update Brad Kahl, MD
12:00pm: Wrap up Michael P. Mullane, MD
Course Directors
Michael Mullane, MD; Medical Oncologist, Advocate Aurora Health. Medical Director, Hereditary Cancer Prevention and Management Center; Advocate Aurora Health
James Weese, MD, FACS; Vice President, Cancer Service Line and Clinical Adjunct Professor of Surgery UW School of Medicine & Public Health, Aurora Cancer Care; Advocate Aurora Health
Faculty
Toni Choueiri, MD; Director, Lank Center for Genitourinary Oncology Department of Medical Oncology, Dana-Farber Cancer Institute; Co-Leader, Kidney Cancer Program; Dana-Farber/Harvard Cancer Center; Jerome and Nancy Kohlberg Professor of Medicine; Harvard Medical School
Lawrence Einhorn, MD; Livestrong Foundation Professor of Oncology Distinguished Professor of Medicine, Department of Medicine, Indiana University
Edward James, MD; Gastrointestinal Oncology- Advocate Medical Group/ Lutheran General Hospital; Cancer Liaison Physician, Advocate Aurora Health, Central Chicagoland Lecturer - Rosalind Franklin Univ. School of Medicine and Science, North Chicago, IL
Brad Kahl, MD; Professor, Department of Medicine, Oncology Division Medical Oncology; Director, Lymphoma Program, Washington University
Rubina Qamar, MD Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health
Corey Shamah, MD Medical Director, Hematology / Oncology, Advocate Aurora Health, Wisconsin
Nataliya Uboha, MD, PhD; Faculty Leader for Cancer Therapy Discovery & Development/Phase I Program; Associate Professor, Department of Medicine, Section of Hematology & Oncology University of Wisconsin
Kari Braun Wisinski, MD; Professor of Medicine; Chief of the Division of Hematology, Medical Oncology and Palliative Care; Co-Lead, Breast Cancer Disease Oriented Team; Associate Director for Clinical Research, Univ. of Wisconsin Carbone Cancer Ctr.
Disclosure
Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.
Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Advocate Aurora Health designates this live activity for a maximum of 3.25 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 3.25 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 3.25 AttendanceAttendance Credit
- 3.25 Approved AMA PRA Category 1 Credit™
VIRTUAL EXHIBIT HALL
Welcome to the Virtual Exhibit Hall. This is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Check out the "booths" below to learn about each exhibitor and get connected!
AstraZeneca | Genentech | Janssen Oncology | Sanofi |
Bristol Myers Squibb | Gilead Oncology | Novartis | Seagen |
Exelixis, Inc. | Guardant | Pfizer | |
The Virtual Exhibit Hall is paid advertising. The use of the Site and the Content, including Third Party Content, is at your own risk.
Price
Click “Take Course” to register for this program.
This conference is being held virtually. Click "Take Course" to see the link to the Zoom meeting.
Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.